CNBC’s Carolin Roth speaks to Tesla Motors Inc (NASDAQ:TSLA), CEO Elon Musk about the development of its $5 billion “gigafactory” in the U.S. “Tesla has dubbed the project the “gigafactory,” and it would make Musk a force in both U.S. manufacturing and electric power. The plant he envisions would have more capacity than any other to make lithium-ion batteries,” Alan Ohnsman Reports From Bloomberg. Tesla Motors Inc (NASDAQ:TSLA), net profit margin is -6.50% and weekly performance is -1.29%. On last trading day company shares ended up $202.30. Analysts mean target price for the company is $224.83. Tesla Motors Inc (NASDAQ:TSLA), distance from 50-day simple moving average (SMA50) is -1.05%.
Qiwi PLC (NASDAQ:QIWI), announced that the Company’s Board of Directors has elected Boris Kim Chairman of the Board. Mr. Kim has been a member of QIWI’s Board of Directors since 2013. Qiwi PLC (NASDAQ:QIWI), fell 7.59% in last trading session and ended the day on $43.97. QIWI, Gross Margin is 46.70% and its return on assets is 14.00%. Qiwi PLC (NASDAQ:QIWI), quarterly performance is 18.14%.
Facebook Inc (NASDAQ:FB), announced the appointment of David Marcus, the former president of PayPal, the payment service of eBay Inc (NASDAQ:EBAY) as vice president of messaging products. Facebook Inc (NASDAQ:FB), shares moved up 4.60% in last trading session and was closed at $65.77, while trading in range of $63.50 – 65.82. Facebook Inc (NASDAQ:FB), year to date (YTD) performance is 20.35%.
salesforce.com, inc. (NYSE:CRM), has launched a developer platform for wearable tech apps called Salesforce Wear, which is “the first initiative for wearable computing in the enterprise.” salesforce.com, inc. (NYSE:CRM), ended the last trading day at $53.06. Company weekly volatility is calculated as 2.19% and price to cash ratio as 37.06. salesforce.com, inc. (NYSE:CRM), showed a positive weekly performance of 4.14%.
On June 04, 2014, Market Exclusive announces that SummerStreet Research Partners has reiterated a BUY rating and year end 2014 price target or $15.10 on Northwest Biotherapeutics, Inc (NASDAQ:NWBO). Northwest Biotherapeutics, Inc (NASDAQ:NWBO), weekly performance is -2.88%. On last trading day company shares ended up $5.73. Analysts mean target price for the company is $10.05. Northwest Biotherapeutics, Inc (NASDAQ:NWBO), distance from 50-day simple moving average (SMA50) is -6.13%.